Research Article
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
Figure 2
SARS-CoV-2-specific T cell responses by CD4 counts. (a) SARS-CoV-2-specific T cell responses against Spike S1 subunit and NMO peptide pools by CD4 count categories at baseline. (b) SARS-CoV-2-specific T cell responses against Spike S1 subunit and NMO peptide pools by CD4 count categories at follow-up.
(a) |
(b) |